Catalyst Wire Dossier Catalyst Wire Dossier

AMP-110

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMP-110, covering 2016-09-30 to 2016-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis [Phase 1]

See pricing